Placental programming of metabolic diseases: molecular pathways from maternal pregnancy complications to offspring metabolic risk
In brief
Placental changes link pregnancy complications to offspring metabolic risk
This review finds that maternal conditions including obesity, diabetes, hypertension and undernutrition alter placental nutrient transport, hormone signaling, inflammation and gene regulation. These changes may converge on offspring risks such as insulin resistance, excess adiposity and impaired glucose control, but how well placental biomarkers can predict or help prevent later disease remains an open question.
- Journal
- Frontiers in endocrinology (Q1)
- Published
- 26 October 2026
- Study design
- Systematic review of cohort studies
- Evidence level
- Level 2, Moderate (CEBM 2a)
- Authors
- Duo Zhou
- PMID
- 43005218
- DOI
- 10.3389/fendo.2026.1860825
Why clinicians should know about it
- Picked for Embryology (top studies of the week, 15 November 2026): Reviews placental mechanisms programming fetal development and later disease
Abstract
INTRODUCTION: The placenta is increasingly recognized as a dynamic regulatory organ that translates both maternal and paternal physiological and pathological states into developmental signals into developmental signals shaping offspring health across the lifespan. In the context of maternal metabolic and obstetric complications, placental function extends far beyond the regulation of fetal growth, influencing key aspects of development including endocrine set points, nutrient allocation, inflammatory responses, vascular adaptation, and molecular programming across fetal organs. RESULTS: This review examines how maternal conditions -such as obesity, gestational diabetes mellitus (GDM), hypertensive disorders of pregnancy, undernutrition, micronutrient imbalance, and maternal inflammatory stress -induce structural, endocrine, vascular, metabolic, and epigenetic alterations in the placenta. We further explore how these changes disrupt critical molecular pathways, including nutrient sensing and transport, oxidative stress responses, mitochondrial function, angiogenesis and glucocorticoid signaling, immune regulation, and gene expression. A central focus is the convergence of placental mechanisms across diverse maternal disorders, leading to shared offspring phenotypes such as insulin resistance, increased adiposity, dyslipidemia, impaired glucose regulation, altered appetite control, and elevated risk of cardiometabolic disease later in life. CONCLUSION: Additionally, we address sex-specific placental adaptations, fetal tissue vulnerability, and the translational potential of placental biomarkers and omics-based approaches supported by mechanistic experimental models. By positioning the placenta as the primary biological interface linking maternal complications to offspring susceptibility to endocrine and complex metabolic diseases, this review provides an integrated framework for understanding developmental programming in metabolic health.
Abstract as published, via PubMed.
For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.